Deltoid administration of Long-Acting Injectable Risperidone: new possibility for patient to make his own choice

Abstract

Risperidon Long-Acting Injections (RLAI) is currently available for deltoid muscle administration. The plasma profiles for risperidon are similar regardless of whether it is injected into the gluteal muscle or the deltoid and administration to both sites are well tolerated.

The main advantage of deltoid administration is the possibility for patient to make his own choice.

Keywords

• risperidon long-acting injections
• deltoid muscle administration
• autonomy